Salsman Jayme, Top Deniz, Barry Christopher, Duncan Roy
Department of Microbiology and Immunology, Dalhousie University, Halifax, Nova Scotia, Canada.
PLoS Pathog. 2008 Mar 7;4(3):e1000016. doi: 10.1371/journal.ppat.1000016.
The reovirus fusion-associated small transmembrane (FAST) proteins function as virus-encoded cellular fusogens, mediating efficient cell-cell rather than virus-cell membrane fusion. With ectodomains of only approximately 20-40 residues, it is unclear how such diminutive viral fusion proteins mediate the initial stages (i.e. membrane contact and close membrane apposition) of the fusion reaction that precede actual membrane merger. We now show that the FAST proteins lack specific receptor-binding activity, and in their natural biological context of promoting cell-cell fusion, rely on cadherins to promote close membrane apposition. The FAST proteins, however, are not specifically reliant on cadherin engagement to mediate membrane apposition as indicated by their ability to efficiently utilize other adhesins in the fusion reaction. Results further indicate that surrogate adhesion proteins that bridge membranes as close as 13 nm apart enhance FAST protein-induced cell-cell fusion, but active actin remodelling is required for maximal fusion activity. The FAST proteins are the first example of membrane fusion proteins that have specifically evolved to function as opportunistic fusogens, designed to exploit and convert naturally occurring adhesion sites into fusion sites. The capacity of surrogate, non-cognate adhesins and active actin remodelling to enhance the cell-cell fusion activity of the FAST proteins are features perfectly suited to the structural and functional evolution of these fusogens as the minimal fusion component of a virus-encoded cellular fusion machine. These results also provide a basis for reconciling the rudimentary structure of the FAST proteins with their capacity to fuse cellular membranes.
呼肠孤病毒融合相关小跨膜(FAST)蛋白作为病毒编码的细胞融合素发挥作用,介导高效的细胞间而非病毒与细胞膜的融合。由于其胞外域仅约20 - 40个残基,尚不清楚如此微小的病毒融合蛋白如何介导融合反应在实际膜融合之前的初始阶段(即膜接触和紧密膜并置)。我们现在表明,FAST蛋白缺乏特异性受体结合活性,并且在其促进细胞间融合的天然生物学环境中,依赖钙黏蛋白来促进紧密膜并置。然而,FAST蛋白并非特异性依赖钙黏蛋白的结合来介导膜并置,这一点从它们在融合反应中有效利用其他黏附素的能力可以看出。结果进一步表明,能使膜间距缩小至13 nm的替代黏附蛋白可增强FAST蛋白诱导的细胞间融合,但最大融合活性需要活跃的肌动蛋白重塑。FAST蛋白是膜融合蛋白的首个例子,它们经过专门进化,作为机会主义融合素发挥作用,旨在利用天然存在的黏附位点并将其转化为融合位点。替代的、非同源黏附素以及活跃的肌动蛋白重塑增强FAST蛋白细胞间融合活性的能力,是这些融合素作为病毒编码细胞融合机器的最小融合组件在结构和功能进化中完美适配的特征。这些结果也为协调FAST蛋白的基本结构与其融合细胞膜的能力提供了基础。